Pancreatic Ductal Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Ductal Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2 [Phase 2]
Phase 2 clinical trial evaluating AZD0901 in advanced solid tumours expressing Claudin18.2 is currently recruiting, including gastric cancer…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: BXCL701 and Pembrolizumab in Patients With Metastatic Pancreatic Ductal Adenocarcinoma [Phase 2]
This is a Phase 2 clinical trial update of BXCL701 in combination with pembrolizumab for metastatic pancreatic ductal adenocarcinoma, with t…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer. [Phase 1, Phase 2]
A Phase 1/2 trial to evaluate the safety and efficacy of XER-001 (amifostine delivered nasoduodenally) in combination with stereotactic body…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Neo-adjuvant FOLF(IRIN)OX for Resectable Pancreatic Adenocarcinoma [Phase 2]
A Phase 2 study evaluating neoadjuvant FOLFIRINOX (FOLF(IRIN)OX) for patients with resectable pancreatic ductal adenocarcinoma has completed…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating pegcetacoplan in combination with modified FOLFIRINOX for metastatic pancreatic ductal adenocarcinoma …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Study Investigating the Association of NP137 With mFOLFIRINOX in Locally Advanced Pancreatic Ductal Adenocarcinoma [Phase 1]
A Phase 1 trial evaluating NP137 in combination with mFOLFIRINOX for locally advanced pancreatic ductal adenocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Study of Pembrolizumab With or Without Defactinib Following Chemotherapy as a Neoadjuvant and Adjuvant Treatment for Resectable Pancreatic Ductal Adenocarcinoma [Phase 2]
Phase 2 trial evaluating pembrolizumab with or without defactinib after chemotherapy as neoadjuvant and adjuvant therapy for resectable panc…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: A Study to Find a Suitable Dose of BI 765883 and to Test Whether it Helps People With Advanced Pancreatic Cancer When Taken Alone or Together With Chemotherapy [Phase 1]
This Phase 1 trial update seeks to identify a suitable dose of BI 765883 and to evaluate whether it benefits patients with advanced pancreat…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: A Study to Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010 [Phase 1]
Phase 1 study GO44010 evaluates RO7496353 in combination with a checkpoint inhibitor (with or without standard chemotherapy) in locally adva…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis [Phase 1]
A Phase 1 trial evaluating intraperitoneal paclitaxel in combination with the NALIRIFOX regimen for pancreatic ductal adenocarcinoma with pe…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: A Study on Multimodal Prognostic Scoring of Advanced PDAC.
A clinical trial evaluating multimodal prognostic scoring for advanced pancreatic ductal adenocarcinoma is currently enrolling by invitation…
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Hepatic Artery Chemotherapy for Patients With Localized Pancreas Cancer [Phase 4]
Phase 4 clinical trial evaluating hepatic artery chemotherapy for patients with localized pancreatic ductal adenocarcinoma; the study is act…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers [Phase 2]
Phase 2 study evaluating the PET imaging agent [18F]FAPI-74 in gastrointestinal cancers has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Study of [68Ga]FAPI-46 PET in Patients With Pancreatic Ductal Carcinoma [Phase 2]
Phase 2 clinical trial evaluating the [68Ga]FAPI-46 PET imaging tracer in pancreatic ductal adenocarcinoma has completed.
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A) [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating MK-2870 alone or with other therapies for gastrointestinal cancers is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Organochlorine Concentration in Adipose Tissue and Pancreatic Adenocarcinoma [NA]
Completed clinical trial investigating the relationship between organochlorine concentration in adipose tissue and pancreatic ductal adenoca…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Outcomes After Laparoscopic Versus Open Pancreaticoduodenectomy [NA]
A clinical trial evaluating outcomes after laparoscopic versus open pancreaticoduodenectomy for pancreatic and periampullary cancers is curr…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: A Study to Compare Tissue and Liquid Biopsies in People With Different Types of Cancer [NA]
This Boehringer Ingelheim-sponsored trial compares tissue and liquid biopsies across multiple cancers—non-small cell lung cancer, colorectal…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400 [Phase 1]
Phase 1 study assessing adverse events and change in disease activity in adults with select advanced solid tumors treated with ABBV-400; the…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: ATRA and SDK002 in Combination With Chemotherapy and Anti-PD-1 Inhibitor in Patients With Advanced Pancreatic Ductal Adenocarcinoma. [Phase 1]
A Phase 1 trial evaluating ATRA and SDK002 in combination with chemotherapy and an anti-PD-1 inhibitor for advanced pancreatic ductal adenoc…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Lead-212 PSV359 Therapy for Patients With Solid Tumors [Phase 1, Phase 2]
Perspective Therapeutics reports that Lead-212 PSV359 Therapy is being studied in Phase 1/2 trials for multiple solid tumors and is currentl…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment [NA]
This clinical trial update describes a biomarker-focused study using tumor DNA and protein profiling to understand how pancreatic ductal ade…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer [Phase 2]
This document reports a Phase 2 clinical trial evaluating glipizide to treat high blood sugar in people with pancreatic cancer; the study is…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating zimberelimab and quemliclustat with chemotherapy for borderline resectable or locally advanced pancreati…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: FAPi PET in Pancreatic Ductal Adenocarcinoma
A clinical trial is evaluating a fibroblast activation protein inhibitor (FAPi) PET imaging agent for pancreatic ductal adenocarcinoma and i…